"Broken Blade" continues to attract "Roblox" players with its fast-paced combat, massive progression system, and challenging RPG gameplay. Developed by Skyrift Devs, the game lets players collect ...

On Friday, Claude Code creator Boris Cherny made an appearance at Meta’s @Scale conference and, surprisingly, the first question from the audience was about loops. “Are loops the next hype cycle,” the ...

If you've been spending hours chopping trees and rolling for better equipment in "Axe RNG", you're probably looking for every advantage you can get. Fortunately, the "Roblox" developers regularly ...

Most security teams think of NTFS junctions and symbolic links as niche file system features. They let one directory point to another, like a shortcut that the OS treats as real. They exist for ...

About two or three weeks ago I was driving east on Palm Coast Parkway and upon approaching the Palm Coast Ford dealership I immediately felt somewhat lost as it was so bright in an area that is ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

Anthropic reveals that Claude now writes over 80% of its production code, with engineers shipping 8x more code per quarter than in 2024. The company’s new Anthropic Institute paper maps the path to ...

Claude now authors over 80% of the code Anthropic merges into production. Engineers shipped 8 times as much code per day in 2026 as in 2024. On a code-speedup test Claude hit 52x, versus 4x for ...

Companies have been developing AI very quickly to stay ahead of the market, but Favaro and Clark argue that a slowdown would allow more time to deal with the technology’s implications. US-based AI ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...